RIZZO, FEDERICA
RIZZO, FEDERICA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Clinical and genetic features of a cohort of patients with MFN2-related neuropathy
2022 E. Abati, A. Manini, D. Velardo, R. Del Bo, L. Napoli, F. Rizzo, M. Moggio, N. Bresolin, E. Bellone, M.T. Bassi, M.G. D'Angelo, G.P. Comi, S. Corti
Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
2022 D. Gagliardi, E. Pagliari, M. Meneri, V. Melzi, F. Rizzo, G.P. Comi, S.P. Corti, M.M. Taiana, M. Nizzardo
Neural stem cell transplantation for neurodegenerative diseases
2020 R. De Gioia, F. Biella, G. Citterio, F. Rizzo, E. Abati, M. Nizzardo, N. Bresolin, G.P. Comi, S. Corti
Animal Models of CMT2A: State-of-art and Therapeutic Implications
2020 R. De Gioia, G. Citterio, E. Abati, M. Nizzardo, N. Bresolin, G.P. Comi, S. Corti, F. Rizzo
Synaptotagmin 13 is neuroprotective across motor neuron diseases
2020 M. Nizzardo, M. Taiana, F. Rizzo, J. Aguila Benitez, J. Nijssen, I. Allodi, V. Melzi, N. Bresolin, G.P. Comi, E. Hedlund, S. Corti
Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons
2019 F. Rizzo, M. Nizzardo, S. Vashisht, E. Molteni, V. Melzi, M. Taiana, S. Salani, P. Santonicola, E. Di Schiavi, M. Bucchia, A. Bordoni, I. Faravelli, N. Bresolin, G.P. Comi, U. Pozzoli, S. Corti
Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art
2019 K. Barbullushi, E. Abati, F. Rizzo, N. Bresolin, G.P. Comi, S. Corti
Downregulation of glutamic acid decarboxylase in Drosophila TDP- 43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses
2018 G. Romano, N. Holodkov, R. Klima, F. Grilli, C. Guarnaccia, M. Nizzardo, F. Rizzo, R. Garcia, F. Feiguin
Genome-wide RNA-seq and proteomic analysis of motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease, partially rescued by riboflavin
2017 F. Rizzo, A. Ramirez, C. Compagnucci, S. Salani, V. Melzi, A. Bordoni, F. Fortunato, N. Bresolin, G.P. Comi, E. Bertini, M. Nizzardo, S. Corti
Peptide-conjugated Morpholino Oligomers for treatment of Spinal Muscular Atrophy
2016 A. Ramirez, M. Rizzuti, F. Rizzo, P. Rinchetti, M. Bucchia, N. Bresolin, G.P. Comi, S. Corti, M. Nizzardo
Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons
2016 F. Rizzo, D. Ronchi, S. Salani, M. Nizzardo, F. Fortunato, A. Bordoni, G. Stuppia, R. Del Bo, D. Piga, R. Fato, N. Bresolin, G.P. Comi, S. Corti
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
2016 M. Nizzardo, C. Simone, F. Rizzo, G. Ulzi, A. Ramirez, M. Rizzuti, A. Bordoni, M. Bucchia, S. Gatti, N. Bresolin, G.P. Comi, S. Corti
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
2015 M. Nizzardo, C. Simone, F. Rizzo, S. Salani, P. Rinchetti, R. Del Bo, S. Dametti, K. Foust, B. Kaspar, N. Bresolin, G. Comi, S. Corti
Morpholino antisense oligomer against SOD1 for amyotrophic lateral sclerosis therapy
2015 C. Simone, M. Nizzardo, F. Rizzo, G. Ulzi, A. Ramirez, M. Bucchia, A. Bordoni, G. Comi, S. Corti
GENERAZIONE DI IPSC COME MODELLO IN VITRO E SVILUPPO DI UN POSSIBILE APPROCCIO TERAPEUTICO PER LA MALATTIA DI CHARCHOT-MARIE-TOOTH DI TIPO 2A(CMT2A)
2015 F. Rizzo
MFN2-related neuropathies: clinical features, molecular pathogenesis and therapeutic perspectives
2015 G. Stuppia, F. Rizzo, G. Riboldi, R. Del Bo, M. Nizzardo, C. Simone, G.P. Comi, N. Bresolin, S. Corti
Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches
2015 M. Nizzardo, C. Simone, S. Dametti, S. Salani, G. Ulzi, S. Pagliarani, F. Rizzo, E. Frattini, F. Pagani, N. Bresolin, G. Comi, S. Corti
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
2015 M. Nizzardo, C. Simone, F. Rizzo, S. Salani, S. Dametti, P. Rinchetti, R. Del Bo, K. Foust, B.K. Kaspar, N. Bresolin, G.P. Comi, S. Corti
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
2014 F. Rizzo, G. Riboldi, S. Salani, M. Nizzardo, C. Simone, S. Corti, E. Hedlund
Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy δ7 mouse model phenotype
2014 M. Nizzardo, C. Simone, S. Salani, M. Ruepp, F. Rizzo, M. Ruggieri, C. Zanetta, S. Brajkovic, H.M. Moulton, O. Müehlemann, N. Bresolin, G.P. Comi, S. Corti